Open access
Open access
Powered by Google Translator Translator

Oncology (all articles)

Small Randomized Trial Suggests a Benefit from Metformin as Adjunctive Therapy in Patients with Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma

16 Sep, 2019 | 00:46h | UTC

Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial – JAMA Oncology (free for a limited period)

Commentary: Metformin Repurposed: Boosts Survival in TKI-Treated Lung Cancer – MedPage Today (free registration required)

 


Observational Study Suggests Antibiotics Can Greatly Impair the Response to Immune Checkpoint Inhibitors in Patients with Cancer

16 Sep, 2019 | 00:48h | UTC

Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer – JAMA Oncology (free for a limited period)

Author Interview: Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer (free audio)

Commentaries: Antibiotics reduce survival rates in cancer patients taking immunotherapy – Imperial College London (free) AND Antibiotics prior to immunotherapy lower survival rate for cancer patients, study says – UPI (free)

 

Related Commentary on Twitter

https://twitter.com/EricTopol/status/1172514038330212357

 


European Guidelines on Endoscopic Management of Polyposis Syndromes

15 Sep, 2019 | 23:58h | UTC

Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Endoscopy (free)

 


[Abstract Only] Study: Liquid vs. Tissue Biopsy for Detecting Acquired Resistance and Tumor Heterogeneity in Gastrointestinal Cancers

15 Sep, 2019 | 23:41h | UTC

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers – Nature Medicine (link to abstract – $ for full-text)

Commentary: Liquid biopsies reveal genetic alterations linked to cancer drug resistance – Broad Institute of MIT and Harvard (free)

 

Related Commentary on Twitter

 


Study: Progress in Cancer Survival, Mortality, and Incidence in Seven High-income Countries 1995–2014

15 Sep, 2019 | 23:35h | UTC

Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study – The Lancet Oncology (free)

Commentaries: Cancer Patients in Rich Countries Are Gaining Years, Study Shows – Bloomberg (free) AND Cancer survival in high income countries is improving but international disparities persist – eCancer News (free)

 

Related Commentary on Twitter

 


Study: Off-target Toxicity is a Common Mechanism of Action of Cancer Drugs Undergoing Clinical Trials

13 Sep, 2019 | 08:19h | UTC

Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials – Science Translational Medicine (free for a limited period)

Commentaries: Cancer drugs don’t always work as intended, researchers warn – Cold Spring Harbor Laboratory (free) AND Why Aren’t Cancer Drugs Better? The Targets Might Be Wrong – The New York Times (10 articles per month are free)

 


[Abstract Only] Study: Older Women with comorbidities Have Little Benefit from Mammography Screening

12 Sep, 2019 | 08:42h | UTC

Screening mammography outcomes: risk of breast cancer and mortality by comorbidity score and age – JNCI: Journal of the National Cancer Institute (link to abstract – $ for full-text)

Commentaries: More evidence screening mammograms not needed for many older women – Reuters (free) AND Mammography unlikely to benefit older women with chronic illnesses – Georgetown University Medical Center (free)

 


Randomized Trial: Effects of Helicobacter pylori Treatment and Vitamin and Garlic Supplementation on Gastric Cancer Incidence and Mortality

12 Sep, 2019 | 08:09h | UTC

Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial – The BMJ (free)

 

Related Commentary on Twitter

 


ASTRO Guideline: Radiation Therapy for Pancreatic Cancer

12 Sep, 2019 | 08:01h | UTC

Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline – Practical Radiation Oncology (free)

Commentaries: ASTRO Guideline on Use of Radiation Therapy for Patients With Pancreatic Cancer – The ASCO Post (free) AND New guideline clarifies role of radiation therapy in pancreatic cancer treatment – American Society for Radiation Oncology (free)

 


[Abstract Only] Observational Study: Men with Prostate Cancer and Pre-existing CV Comorbidities Have Increased Mortality Risk Following Oral Antiandrogen Therapy

12 Sep, 2019 | 07:53h | UTC

Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities – European Urology (link to abstract – $ for full-text)

Commentaries: CVD Prior to Oral Antiandrogen Therapy for Prostate Cancer Increases Mortality Risk – Cancer Therapy Advisor (free) AND Risks of Novel Oral Prostate Cancer Therapies and Pre-existing Conditions – Thomas Jefferson University (free)

 


Systematic Review: Follow‐up Strategies for Patients Treated for Non‐metastatic Colorectal Cancer

11 Sep, 2019 | 00:03h | UTC

Follow‐up strategies for patients treated for non‐metastatic colorectal cancer – Cochrane Library (free)

Summary: Follow-up strategies for participants treated for non-metastatic colorectal cancer – Cochrane Library (free)

 


NCCN Guideline: Small Bowel Adenocarcinoma

10 Sep, 2019 | 01:18h | UTC

Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network (free)

 


NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment of Colorectal Cancer

10 Sep, 2019 | 01:19h | UTC

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019 – Journal of the National Comprehensive Cancer Network (free)

 


[Abstract Only] Randomized Trial: Adjuvant Radiotherapy Following Radical Prostatectomy vs. Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension

10 Sep, 2019 | 00:56h | UTC

Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension – European Urology (link to abstract – $ for full-text)

Commentaries: Adjuvant Radiotherapy After Radical Prostatectomy vs Radical Prostatectomy Alone in Patients With Positive Margins or Extracapsular Extension – The ASCO Post (free) AND Adjuvant radiotherapy may be beneficial in treating locally advanced prostate cancer – University of Helsinki (free)

Source: EvidenceAlerts

 


[Abstract Only] Another Study Points to Increased Colorectal Cancer Incidence in Young Adults

8 Sep, 2019 | 23:05h | UTC

Global patterns and trends in colorectal cancer incidence in young adults – Gut (link to abstract – $ for full-text)

Commentaries: Global analysis finds early onset colorectal cancer rising in many high-income countries – American Cancer Society (free) AND Increase in CRC in Young Adults in Many High-Income Countries – Medscape (free registration required)

Related: More Colon Cancer Cases are Being Diagnosed in People Under 50 (link to abstract and commentaries)

 


Systematic Review: Hypofractionation (Fewer, Larger Doses of Daily Radiation) for Clinically Localized Prostate Cancer Results in Similar Oncologic Outcomes

8 Sep, 2019 | 23:00h | UTC

Hypofractionation for clinically localized prostate cancer – Cochrane Library (free)

 


Systematic Review: Taxanes for Adjuvant Treatment of Early Breast Cancer

8 Sep, 2019 | 22:59h | UTC

Taxanes for adjuvant treatment of early breast cancer – Cochrane Library (free)

Summary: Taxane-containing chemotherapy for women after surgery for early breast cancer – Cochrane Library (free)

 


Population-based Cohort Study: Exposure to Diagnostic Low-Dose Ionizing Radiation Associated with Increased Risk for Many Types of Cancers

5 Sep, 2019 | 08:27h | UTC

Association of Exposure to Diagnostic Low-Dose Ionizing Radiation With Risk of Cancer Among Youths in South Korea – JAMA Network Open (free)

 


ASCO Guideline: Use of Endocrine Therapy for Breast Cancer Risk Reduction

5 Sep, 2019 | 08:15h | UTC

Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update – Journal of Clinical Oncology (free)

Related: USPSTF Recommendation Statement: Medication Use to Reduce Risk of Breast Cancer (free)

 


USPSTF Recommendation Statement: Medication Use to Reduce Risk of Breast Cancer

4 Sep, 2019 | 09:11h | UTC

Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement – JAMA (free)

Recommendation Summary: Medication Use to Reduce Risk of Breast Cancer (free)

Editorials: Medications to Reduce Breast Cancer Risk: Promise and Limitations (free for a limited period) AND Breast Cancer Chemoprevention—Can We Make a Case for Precision Medicine? (free for a limited period)

Evidence Report and Systematic Review: Medication Use for the Risk Reduction of Primary Breast Cancer in Women – US Preventive Services Task Force (free)

Author Interview: USPSTF Recommendation: Medication Use to Reduce Risk of Breast Cancer (free audio)

Commentaries: Medication can lower some women’s risk of breast cancer – Reuters (free) AND USPSTF: Aromatase Inhibitors Recommended to Help Prevent Breast Cancer – NEJM Journal Watch (free)

 


#ESCCongress – Study: Cancer Now Leading Cause of Death in High-income Countries

4 Sep, 2019 | 09:32h | UTC

Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study – The Lancet (free for a limited period – registration required)

Related Study: Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study – The Lancet (free for a limited period – registration required)

Commentaries: Cancer now leading cause of death in high-income countries — while heart disease burden persists in low-income and middle-income countries – The Lancet (free) AND Cardiovascular Disease Leading Cause of Death World-Wide, but Cancer Rising Cause in Rich Countries: Study – McMaster University (free) AND Cancer ‘biggest middle-age killer in rich nations’ – BBC (free) AND Cancer overtakes heart disease as biggest rich-world killer – Reuters (free) AND Cancer now tops heart disease as the No. 1 cause of death in these countries – CNN (free)

 

Related Commentary on Twitter


Meta-Analysis: Menopausal Hormone Therapy Increases Breast Cancer Risk

30 Aug, 2019 | 08:55h | UTC

Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence – The Lancet (free)

Commentaries: Menopausal hormones: definitive evidence for breast cancer – The Lancet (free) AND Menopausal hormone therapy and 20-year breast cancer mortality – The Lancet (free) AND Hormone therapy during menopause raises breast cancer risk for years, study finds – STAT (free) AND Expert reaction to study looking at HRT use and risk of breast cancer – Science Media Centre (free)

 


Cardiovascular Toxicity of Immune Checkpoint Inhibitors in Cancer Patients

28 Aug, 2019 | 02:11h | UTC

Cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: A review when cardiology meets immuno-oncology – Journal of the Formosan Medical Association (free)

Related: Immune Checkpoint Inhibitor Toxicities (free guidelines and reviews on the subject)

 


Meta-Analysis: Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors for the Treatment of Melanoma

28 Aug, 2019 | 02:11h | UTC

Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis – JAMA Network Open (free)

Commentary: Risk of Cardiovascular Adverse Events in Patients With Melanoma Treated With Combined BRAF and MEK Inhibition vs BRAF Inhibition Alone – The ASCO Post (free)

 


Review: Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer

28 Aug, 2019 | 02:06h | UTC

Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer: A Review – JAMA (free for a limited period)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.